Physician profile
Scott Bennion
NPI 1952317505
$1,601.87
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $360 · 2020: $142 · 2021: $319 · 2022: $501 · 2023: $171 · 2024: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $171 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $170.89 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $109.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $643.73 | 2019-2024 | Skyrizi |
| Regeneron Healthcare Solutions, INC. | $132.60 | 2021-2023 | Dupixent |
| Biofrontera INC. | $121.73 | 2019 | |
| Novartis Pharmaceuticals Corporation | $113.72 | 2019-2022 | |
| Amgen INC. | $107.35 | 2019-2023 | Otezla |
| Janssen Biotech, INC. | $104.27 | 2021-2023 | Tremfya |
| Lilly USA, LLC | $100.58 | 2019-2023 | Taltz, Olumiant |
| Allergan, INC. | $74.71 | 2019-2022 | |
| Genzyme Corporation | $69.00 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $25.38 | 2023 | |
| Pfizer INC. | $25.12 | 2020-2021 | |
| Ucb, INC. | $23.83 | 2021 | |
| Incyte Corporation | $19.09 | 2022 | |
| Galderma Laboratories, L.P. | $16.27 | 2019 | |
| Tactile Systems Technology INC | $12.63 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $11.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Bennion listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.